TCOV
TMDX icon

Trust Company of Vermont’s Transmedics TMDX Stock Holding History

Trust Company of Vermont’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.31K Buy
+110
New +$9.31K ﹤0.01% 952
2025
Q4 		$13.4K Hold
110
– – ﹤0.01% 812
2025
Q3 		$12.3K Sell
110
-40
-27% -$4.68K ﹤0.01% 803
2025
Q2 		$20.1K Sell
150
-35
-19% -$3.84K ﹤0.01% 715
2025
Q1 		$12.4K Hold
185
– – ﹤0.01% 738
2024
Q4 		$11.5K Buy
185
+75
+68% +$6.98K ﹤0.01% 758
2024
Q3 		$17.3K Hold
110
– – ﹤0.01% 685
2024
Q2 		$16.6K Sell
110
-27
-20% -$3.24K ﹤0.01% 636
2024
Q1 		$10.1K Hold
137
– – ﹤0.01% 685
2023
Q4 		$10.8K Hold
137
– – ﹤0.01% 607
2023
Q3 		$7.5K Buy
+137
New +$9.86K ﹤0.01% 678

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Trust Company of Vermont's TMDX Position: Q2 2026 in Review

Trust Company of Vermont opened a new position in Transmedics (TMDX) in Q2 2026: 110 shares worth $7.31K. The stake represents ﹤0.01% of the portfolio and ranks #952 among its holdings. This is a return to the name: Trust Company of Vermont previously reported a position in TMDX as recently as Q4 2025.

Trust Company of Vermont first reported a position in TMDX in Q3 2023 and has held it in 11 quarters since. The position peaked at $20.1K in Q2 2025. 166 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Trust Company of Vermont held 110 shares of Transmedics worth $7.31K as of Q2 2026.
  • Transmedics was a new Trust Company of Vermont position in Q2 2026.
  • Transmedics made up ﹤0.01% of Trust Company of Vermont's portfolio in Q2 2026, its #952 holding.
  • Trust Company of Vermont first reported a position in Transmedics in Q3 2023 and has held it in 11 quarters since.
  • Trust Company of Vermont's Transmedics position peaked at $20.1K in Q2 2025.
  • 166 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Trust Company of Vermont's 13F filing for Q2 2026, filed 7 Aug 2026.